[{"orgOrder":0,"company":"Bio-gen Extracts","sponsor":"Bio-gen Extracts","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"AUSTRALIA","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Carotenoids","moa":"||Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase IV","graph3":"Bio-gen Extracts","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Oral Capsule","sponsorNew":"Bio-gen Extracts \/ Bio-gen Extracts","highestDevelopmentStatusID":"11","companyTruncated":"Bio-gen Extracts \/ Bio-gen Extracts"},{"orgOrder":0,"company":"Bio-gen Extracts","sponsor":"Bio-gen Extracts","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"Beetroot","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Bio-gen Extracts","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bio-gen Extracts \/ Bio-gen Extracts","highestDevelopmentStatusID":"1","companyTruncated":"Bio-gen Extracts \/ Bio-gen Extracts"}]

Find Clinical Drug Pipeline Developments & Deals by Bio-gen Extracts

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 14, 2025

                          Lead Product(s) : Carotenoids,Inapplicable

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Phase IV

                          Recipient : Bio-gen Extracts

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          September 19, 2024

                          Lead Product(s) : Beetroot,Caffeine

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Loughborough University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank